Twist Bioscience Corporation (TWST)

NASDAQ: TWST · Real-Time Price · USD

145.59

+9.26 (6.79%)

At close: Aug 21, 2026, 4:00 PM EDT

145.09

-0.50 (-0.34%)

Pre-market: Aug 24, 2026, 6:43 AM EDT

Twist Bioscience Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	431.8	376.57	312.97	245.11	203.57	132.33
Revenue Growth	19.19%	20.32%	27.69%	20.41%	53.83%	46.87%
Gross Profit	224.39	191	133.35	89.73	84.24	51.71
Operating Income	-137.77	-136.26	-175.9	-206.9	-249.02	-153.26
Net Income	-136.72	-77.67	-208.73	-204.62	-217.86	-152.1
Earnings Per Share	-2.23	-1.30	-3.60	-3.60	-4.04	-3.15
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Americas	257.24	225.58	193.88	151.26	122.47	77.91
Europe, Middle East and Africa (EMEA)	143.89	124.24	92.57	71.39	62.08	44.12
Asia Pacific (APAC)	30.67	26.75	26.52	22.46	19.01	10.3
Total	431.8	376.57	312.97	245.11	203.57	132.33

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Investments	166.84	232.43	276.4	336.41	504.97	477.86
Total Debt	108.59	90.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	58.25	141.86	191.37	242.34	410.06	414.94
Net Cash Growth	-63.05%	-25.87%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	0.95	2.37	3.30	4.26	7.61	8.60

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Cash Flow	-53.07	-47.63	-64.09	-142.47	-124.39	-112.24
Capital Expenditures	-40.05	-28	-5.08	-27.78	-101.86	-27.06
Free Cash Flow	-93.12	-75.63	-69.17	-170.25	-226.24	-139.31
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Gross Margin	51.96%	50.72%	42.61%	36.61%	41.38%	39.08%
Operating Margin	-31.91%	-36.18%	-56.20%	-84.41%	-122.33%	-115.81%
Pretax Margin	-31.46%	-20.43%	-66.51%	-83.01%	-112.14%	-116.39%
Profit Margin	-31.66%	-20.63%	-66.69%	-83.48%	-107.02%	-114.94%
FCF Margin	-21.57%	-20.08%	-22.10%	-69.46%	-111.14%	-105.27%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PS Ratio	21.14	4.51	8.46	4.74	9.76	39.85